Myriad Genetics (MYGN) EPS (Diluted) Growth (3y) (2012 - 2026)
Myriad Genetics (MYGN) EPS (Diluted) Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.44 Bn | 209.37 Bn | 8.34 Bn | 10.52% |
| 2 | Danaher | 139.95 Bn | 135.60 Bn | 3.61 Bn | -6.10% |
| 3 | Idexx Laboratories | 46.16 Bn | 45.96 Bn | 779.09 Mn | 16.91% |
| 4 | Agilent Technologies | 39.67 Bn | 37.87 Bn | 990.00 Mn | 5.61% |
| 5 | Iqvia Holdings | 39.29 Bn | 37.21 Bn | 1.44 Bn | -2.93% |
| 6 | Natera | 38.61 Bn | 37.51 Bn | 696.04 Mn | 21.11% |
| 7 | Illumina | 29.99 Bn | 28.82 Bn | 770.00 Mn | 42.83% |
| 8 | Mettler Toledo International | 28.57 Bn | 28.51 Bn | 650.22 Mn | 6.03% |
| 9 | Quest Diagnostics | 26.17 Bn | 25.55 Bn | 1.03 Bn | 10.87% |
| 10 | Myriad Genetics | 296.09 Mn | 171.69 Mn | 137.60 Mn | 18.52% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 18.52% |
| Dec 31, 2025 | 45.42% |
| Sep 30, 2025 | 12.21% |
| Jun 30, 2025 | -173.12% |
| Mar 31, 2025 | 83.77% |
| Dec 31, 2024 | -68.85% |
| Sep 30, 2024 | -41.04% |
| Jun 30, 2024 | -88.08% |
| Mar 31, 2024 | 17.75% |
| Dec 31, 2023 | 19.03% |
| Sep 30, 2023 | 33.00% |
| Jun 30, 2023 | 14.68% |
| Mar 31, 2023 | 24.22% |
| Dec 31, 2022 | -67.56% |
| Sep 30, 2022 | -15.88% |
| Jun 30, 2022 | -45.80% |
| Mar 31, 2022 | -68.43% |
| Dec 31, 2021 | -69.47% |
| Sep 30, 2021 | 209.14% |
| Jun 30, 2021 | -32.04% |